资讯|新利18手机|病例

搜索

首页 18luck西部 专业文章 医学进展 签约作者 病例中心 快问诊所 新利网官方网站 医学考试 在线题库 医学会议

您所在的位置:首页>呼吸科诊疗指南> 2000ATS/ERS国际共识声明:特发性肺纤维化的诊断和治疗

2000ATS/ERS国际共识声明:特发性肺纤维化的诊断和治疗

2013-09-11 14:32 阅读:1522 来源:爱爱医资源网 责任编辑:林晓枫
[导读]《2000ATS/ERS国际共识声明:特发性肺纤维化的诊断和治疗》内容预览 OBJECTIVE This is an international consensus statement defining the diag- nosis, evaluation, and management of patients with IPF that has been produced as a collaborative effo

《2000ATS/ERS国际共识声明:特发性肺纤维化的诊断和治疗》内容预览

OBJECTIVE
This is an international consensus statement defining the diag- nosis, evaluation, and management of patients with IPF that has been produced as a collaborative effort from the Ameri- can Thoracic Society (ATS), European Respiratory Society (ERS), and the American College of Chest Physicians (ACCP). The purpose of this consensus statement is to provide assis- tance to clinicians in the diagnosis and management of idio- pathic pulmonary fibrosis (IPF). The targeted providers are pulmonary subspecialists.
PARTICIPANTS Panel members are experts in adult pulmonary diseases. Panel members were nominated by the supporting associations. The chair was selected by the American Thoracic Society. Panel members were selected because of an interest and expertise in the interstitial lung disease and to provide a range of opinions, expertise, and geography.

EVIDENCE
The expert panel was provided with background articles that reviewed the existing scientific evidence. Relevant articles from the medical literature were identified by a MedLine search (1966 to December 1998) of English language articles or arti- cles with English abstracts, the bibliographies of the articles retrieved, and the authors’ files. In addition, articles in other languages were also obtained from the bibliographies of the articles retrieved and were reviewed or translated by pulmo- nary physicians knowledgeable in this area. All articles in which IPF was identified were included in this review. More than 3,500 published reports were critically reviewed for infor- mation on IPF, including its physiologic, radiologic, and patho- logical findings; its pathogenesis, epidemiology, clinical pre- sentation, and staging; its inheritance or familial occurrence; its treatment (including lung transplant); and its prognosis. The panel was divided into subgroups responsible for the review of the data and writing of a specific section of the state-ment. The final statement was drafted after a series of meet-ings of the entire committee.

点击下载完整版:《2000ATS/ERS国际共识声明:特发性肺纤维化的诊断和治疗》


分享到:
版权声明:

本站所注明来源为"爱爱医"的文章,版权归作者与本站共同所有,非经授权不得转载。

本站所有转载文章系出于传递更多信息之目的,且明确注明来源和作者,不希望被转载的媒体或个人可与我们

联系zlzs@120.net,我们将立即进行删除处理

意见反馈关于我们隐私保护版权声明友情链接联系我们

Copyright 2002-2024 Iiyi.Com All Rights Reserved

Baidu
map